Mirxes Pte. LTD.

UEI
XDY8YFPTQHM1
CAGE
Q3623
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
International Organization
SAM.gov registration date
Website
mirxes.com
Founded
2014
Employees
251-1K
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $72,000
FY2023 $110,400

Contract awards

Award Agency Obligated Awarded
Stereo-SEQ service 12305B24P0095 Northeast Area (FRIID) $36,000
Mirxes - 4 chip stereo-SEQ service 12305B24P0011 Northeast Area (FRIID) $36,000
Stereo-sequencing 12305B23P0272 Northeast Area (FRIID) $110,400

Similar vendors

About the company

Mirxes Pte. LTD. is an international, for-profit organization registered to receive awards from the U.S. federal government. The company specializes in providing advanced genomic sequencing services, particularly stereo-sequencing and spatial transcriptomics capabilities. These cutting-edge technologies support research efforts in gene activity measurement and DNA sequencing, primarily for agricultural research purposes. Mirxes Pte. LTD. has been actively engaged with the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS), offering specialized services that contribute to the advancement of genomic technologies and genetic improvement of ruminants.

The company has secured multiple federal contract awards from the USDA-ARS Field Research Implementation and Information Delivery Northeast Area. These awards include a $36,000 purchase order for STEREO-SEQ SERVICE, providing spatial transcriptomics capability with 500-nanometer resolution to support the Animal Genomics and Improvement Laboratory's mission. Another $36,000 contract was awarded for MIRXES - 4 CHIP STEREO-SEQ SERVICE, supporting agricultural research and information delivery programs in the Northeast region. Additionally, Mirxes Pte. LTD. received a larger $110,400 contract for stereo-sequencing services to advance genomic technologies in agricultural research. All these contracts were awarded as firm fixed-price purchase orders without any set-aside designations, indicating that Mirxes Pte. LTD. competes in full and open competition for these specialized services.

Quick answers

Is Mirxes Pte. LTD. registered in SAM.gov?

Mirxes Pte. LTD.'s SAM.gov registration expired on September 25, 2025.

What is Mirxes Pte. LTD.'s CAGE code?

Mirxes Pte. LTD.'s CAGE code is Q3623, and its Unique Entity ID (UEI) is XDY8YFPTQHM1.

How much has Mirxes Pte. LTD. received in federal contracts?

Federal contracts obligated $182,400 to Mirxes Pte. LTD. in fiscal years 2023 through 2027.

What is Mirxes Pte. LTD.'s most recent federal award?

Mirxes Pte. LTD.'s most recent federal contract award is Stereo-SEQ service (12305B24P0095), from Northeast Area (FRIID), on May 20, 2024.

On GovTribe

See Mirxes Pte. LTD.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe